Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2022-06-03 Call Transcript
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Recording of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of an earnings call for the quarter and financial year ended March 31, 2022. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides a link to the audio recording on the company's website. The document is short (1569 characters) and serves as an announcement of the earnings call audio recording rather than the transcript or detailed financial results. Therefore, it is best classified as a Call Transcript (CT) related filing, specifically an announcement of the earnings call audio recording, which aligns with the Call Transcript category rather than an Earnings Release or Regulatory Filing. Confidence is high due to clear mention of earnings call audio recording and regulatory reference.
2022-06-03 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is an invitation to a conference call discussing the financial and operational performance for the quarter and year ended 31 March 2022. It includes details about the date, time, dial-in numbers, and participants. There is no actual financial data or report content, only an announcement of the call. This matches the definition of a Call Transcript (CT) document type, as it is related to a company conference call. Although the transcript itself is not provided, the invitation is closely related to the call transcript category rather than other report types or announcements. Given the content and purpose, the best classification is Call Transcript (CT).
2022-05-31 English
Press Release
Earnings Release Classification · 95% confidence The document is titled as an "Earnings Press Release" and contains detailed financial results for the quarter and financial year ended March 31, 2022. It includes key financial metrics such as revenue, EBITDA, PAT, and dividend information, along with commentary from the Executive Chairman. The document is a press release announcing the company's financial performance rather than a full comprehensive financial report. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks detailed financial statements and extensive analysis. The document is not a Call Transcript, Board/Management Information, or any other category. Therefore, the document fits best as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. The document length (11,464 characters) supports it being a detailed press release but not a full report.
2022-05-28 English
Investor Presentation
Regulatory Filings
2022-05-28 English
Outcome of Board Meeting
Regulatory Filings
2022-05-28 English
Dividend
Regulatory Filings
2022-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.